MindMed Revenue and Competitors

Location

#8111

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • MindMed's estimated annual revenue is currently $16.9M per year.(i)
  • MindMed's estimated revenue per employee is $159,387

Employee Data

  • MindMed has 106 Employees.(i)
  • MindMed grew their employee count by 12% last year.

MindMed's People

NameTitleEmail/Phone
1
Chief Corporate Affairs OfficerReveal Email/Phone
2
Chief Regulatory and Quality Assurance OfficerReveal Email/Phone
3
Chief Medical OfficerReveal Email/Phone
4
CEOReveal Email/Phone
5
Chief Accounting OfficerReveal Email/Phone
6
VP, Global Marketing, Strategic Insights & Digital InnovationReveal Email/Phone
7
VP, Global Marketing, Strategic Insights and Digital InnovationReveal Email/Phone
8
VP, Global Medical AffairsReveal Email/Phone
9
VP Research and Development StrategyReveal Email/Phone
10
VP Pharmaceutical DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.8M13819%N/AN/A
#2
$11.3M7525%N/AN/A
#3
$6040M286095%$1.5B$3.3B
#4
$7.5M9053%N/AN/A
#5
$16.9M10612%N/AN/A
Add Company

What Is MindMed?

MindMed is a psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC. The MindMed executive team brings extensive biopharmaceutical experience to the company's groundbreaking approach to developing the next-generation of psychedelic inspired medicines and therapies. MindMed trades on the Canadian exchange NEO under the symbol MMED. MindMed is also traded in the United States under the symbol MMEDF and in Germany under the symbol MMQ. For more information: www.mindmed.co

keywords:N/A

N/A

Total Funding

106

Number of Employees

$16.9M

Revenue (est)

12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MindMed News

2022-03-22 - MindMed Announces Transition of CFO

MindMed is a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on...

2022-03-22 - MindMed Reports Full Year 2021 Financial Results and ...

MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.1M106-23%$118M
#2
$14.8M106-33%$19.3M
#3
$14.5M10631%$4.3M
#4
$29.3M106-12%N/A
#5
$29.7M106-12%N/A